Man Group
TMCI icon

Man Group’s Treace Medical Concepts TMCI Stock Holding History

Man Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,975
Closed -$92.1K – 2387
2025
Q1 		$92.1K Buy
+10,975
New +$98.6K ﹤0.01% 2116
2022
Q4 		– Sell
-20,791
Closed -$459K – 2221
2022
Q3 		$459K Buy
+20,791
New +$402K ﹤0.01% 1542
2022
Q2 		– Sell
-40,058
Closed -$675K – 1728
2022
Q1 		$757K Sell
40,058
-17,238
-30% -$335K ﹤0.01% 1455
2021
Q4 		$1.07M Buy
+57,296
New +$1.18M ﹤0.01% 1321

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group's TMCI Position: Q2 2025 in Review

Man Group sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 10,975 shares — an estimated $92.1K sold.

Man Group first reported a position in TMCI in Q4 2021 and held it in 4 quarters. The position peaked at $1.07M in Q4 2021. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Man Group reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Man Group sold 10,975 Treace Medical Concepts shares in Q2 2025, an estimated $92.1K.
  • Man Group first reported a position in Treace Medical Concepts in Q4 2021 and held it in 4 quarters.
  • Man Group's Treace Medical Concepts position peaked at $1.07M in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.